presentation available

The presentation given at the talk on 24 Feb is now on the MBP web site. Some new data on the trials has been included. A shareholder update to be given in 2-3 weeks.

Info:

Possible increase in weight loss with dosage lower than 1mg. A study is to be undertaken later in the year to determine optimum dosage.

Weight loss at least as good as currently marketed drugs.

Safety and side effects better than existing drugs.

A number of positive side effects noted.

Cost of manufacture, cents per dose at 1mg level.

Males have much greater weight loss than females for higher dosage.

Average of ~2.7cm reduction in waste line for those taking 1mg compared to ~0.2cm for placebo.

G